AAAAAA
Results: 1-25/30
Authors:
Yamane, K
Ihn, H
Kubo, M
Kuwana, M
Asano, Y
Yazawa, N
Tamaki, K
Citation: K. Yamane et al., Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma, RHEUMATOLOG, 40(6), 2001, pp. 683-686
Authors:
Yazawa, N
Ihn, H
Yamane, K
Etoh, T
Tamaki, K
Citation: N. Yazawa et al., The successful treatment of prurigo pigmentosa with macrolide antibiotics, DERMATOLOGY, 202(1), 2001, pp. 67-69
Authors:
Yamane, K
Ihn, H
Kubo, M
Kuwana, M
Asano, Y
Yazawa, N
Tamaki, K
Citation: K. Yamane et al., Anti-U1RNP antibodies in patients with localized scleroderma, ARCH DERM R, 293(9), 2001, pp. 455-459
Authors:
Ihn, H
Ihn, Y
Trojanowska, M
Citation: H. Ihn et al., Sp1 phosphorylation induced by serum stimulates the human alpha 2 (I) collagen gene expression, J INVES DER, 117(2), 2001, pp. 301-308
Authors:
Kubo, M
Ihn, H
Yamane, K
Asano, Y
Jinnin, M
Tamaki, K
Citation: M. Kubo et al., Differential expression of transforming growth factor-beta receptors in squamous cell carcinoma, BR J DERM, 145(5), 2001, pp. 840-842
Authors:
Yazawa, N
Ihn, H
Yamane, K
Kubo, M
Fujimoto, M
Kikuchi, K
Soma, Y
Tamaki, K
Citation: N. Yazawa et al., Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis, BR J DERM, 145(4), 2001, pp. 676-678
Authors:
Asano, Y
Ihn, H
Yamane, K
Yazawa, N
Kubo, M
Fujimoto, M
Tamaki, K
Citation: Y. Asano et al., Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis, ARTH RHEUM, 44(6), 2001, pp. 1363-1369
Authors:
Kubo, M
Ihn, H
Yamane, K
Tamaki, K
Citation: M. Kubo et al., Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma, ARTH RHEUM, 44(3), 2001, pp. 731-734
Authors:
Ihn, H
Yamane, K
Kubo, M
Tamaki, K
Citation: H. Ihn et al., Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts - Association with increased expression of transforming growth factor beta receptors, ARTH RHEUM, 44(2), 2001, pp. 474-480
Authors:
Yamane, K
Ihn, H
Kubo, M
Asano, Y
Yazawa, N
Tamaki, K
Kuwana, M
Citation: K. Yamane et al., Anti-U3 snRNP antibodies in localised scleroderma, ANN RHEUM D, 60(12), 2001, pp. 1157-1158
Authors:
Kubo, M
Ihn, H
Yamane, K
Kikuchi, K
Yazawa, N
Soma, Y
Tamaki, K
Citation: M. Kubo et al., Serum KL-6 in adult patients with polymyositis and dermatomyositis, RHEUMATOLOG, 39(6), 2000, pp. 632-636
Authors:
Yamane, K
Ihn, H
Asano, Y
Yazawa, N
Kubo, M
Kikuchi, K
Soma, Y
Tamaki, K
Citation: K. Yamane et al., Clinical and laboratory features of scleroderma patients with pulmonary hypertension, RHEUMATOLOG, 39(11), 2000, pp. 1269-1271
Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody
Authors:
Sato, S
Hasegawa, M
Ihn, H
Kikuchi, K
Takehara, K
Citation: S. Sato et al., Clinical significance of antinuclear matrix antibody in serum from patients with anti-U1RNP antibody, ARCH DERM R, 292(2-3), 2000, pp. 55-59
Authors:
Nagaoka, T
Sato, S
Hasegawa, M
Ihn, H
Takehara, K
Citation: T. Nagaoka et al., Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma, J RHEUMATOL, 27(8), 2000, pp. 1917-1921
Authors:
Yamane, K
Ihn, H
Kubo, M
Yazawa, N
Kikuchi, K
Soma, Y
Tamaki, K
Citation: K. Yamane et al., Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis, J RHEUMATOL, 27(4), 2000, pp. 930-934
Authors:
Ihn, H
Yazawa, N
Kubo, M
Yamane, K
Sato, S
Fujimoto, M
Kikuchi, K
Soma, Y
Tamaki, K
Citation: H. Ihn et al., Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease, J RHEUMATOL, 27(3), 2000, pp. 698-702
Authors:
Yamane, K
Ihn, H
Kubo, M
Yazawa, N
Kikuchi, K
Soma, Y
Tamaki, K
Citation: K. Yamane et al., Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma, J AM ACAD D, 42(1), 2000, pp. 64-69
Authors:
Yazawa, N
Kikuchi, K
Ihn, H
Fujimoto, M
Kubo, M
Tamaki, T
Tamaki, K
Citation: N. Yazawa et al., Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis, J AM ACAD D, 42(1), 2000, pp. 70-75
Authors:
Ihn, H
Tamaki, K
Citation: H. Ihn et K. Tamaki, Competition analysis of the human alpha 2(I) collagen promoter using synthetic oligonucleotides, J INVES DER, 114(5), 2000, pp. 1011-1016
Authors:
Ihn, H
Tamaki, K
Citation: H. Ihn et K. Tamaki, Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway, J IMMUNOL, 165(4), 2000, pp. 2149-2155
Authors:
Ihn, H
Sato, S
Fujimoto, M
Igarashi, A
Yazawa, N
Kubo, M
Kikuchi, K
Takehara, K
Tamaki, K
Citation: H. Ihn et al., Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis, CLIN EXP IM, 119(1), 2000, pp. 203-209
Authors:
Kubo, M
Ihn, H
Yamane, K
Yazawa, N
Kikuchi, K
Soma, Y
Tamaki, K
Citation: M. Kubo et al., Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis, BR J DERM, 143(2), 2000, pp. 392-398
Authors:
Ihn, H
Tamaki, K
Citation: H. Ihn et K. Tamaki, Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts - Association with increased expression of the type I collagen gene, ARTH RHEUM, 43(10), 2000, pp. 2240-2247
Authors:
Hasegawa, M
Sato, S
Ihn, H
Takehara, K
Citation: M. Hasegawa et al., Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6receptor by cultured peripheral blood mononuclear cells from patients withsystemic sclerosis, RHEUMATOLOG, 38(7), 1999, pp. 612-617
Authors:
Yano, S
Ihn, H
Nakamura, K
Okochi, H
Tamaki, K
Citation: S. Yano et al., Antinuclear and antithyroid antibodies in 68 Japanese patients with Alopecia areata, DERMATOLOGY, 199(2), 1999, pp. 191-191